Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Management of asymptomatic coccidioidomycosis in patients with rheumatic diseases.

Bilal J, Kollampare S, Bode B, Lisse JR, Hoover SE, Sudano D, Ampel NM.

Rheumatol Int. 2019 Jul;39(7):1257-1262. doi: 10.1007/s00296-019-04307-7. Epub 2019 May 7.

PMID:
31065743
2.

Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013-2018.

Mafi N, Yaglom HD, Levy C, Taylor A, O'Grady C, Venkat H, Komatsu KK, Roller B, Seville MT, Kusne S, Po JL, Thorn S, Ampel NM.

Emerg Infect Dis. 2019 Apr;25(4):649-653. doi: 10.3201/eid2504.181369.

3.

Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.

Hung CY, Zhang H, Castro-Lopez N, Ostroff GR, Khoshlenar P, Abraham A, Cole GT, Negron A, Forsthuber T, Peng T, Galgiani JN, Ampel NM, Yu JJ.

Infect Immun. 2018 Oct 25;86(11). pii: e00070-18. doi: 10.1128/IAI.00070-18. Print 2018 Nov.

4.

Ex Vivo Cytokine Release, Determined by a Multiplex Cytokine Assay, in Response to Coccidioidal Antigen Stimulation of Whole Blood among Subjects with Recently Diagnosed Primary Pulmonary Coccidioidomycosis.

Ampel NM, Robey I, Nguyen CT, Roller B, August J, Knox KS, Pappagianis D.

mSphere. 2018 May 16;3(3). pii: e00065-18. doi: 10.1128/mSphere.00065-18. eCollection 2018 May-Jun.

5.

Coccidioidomycosis in selected immunosuppressed hosts.

Blair JE, Ampel NM, Hoover SE.

Med Mycol. 2019 Feb 1;57(Supplement_1):S56-S63. doi: 10.1093/mmy/myy019. Review.

PMID:
29669037
6.

Coccidioidomycosis among persons undergoing lung transplantation in the coccidioidal endemic region.

Chaudhary S, Meinke L, Ateeli H, Knox KS, Raz Y, Ampel NM.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12713. Epub 2017 Jun 22.

PMID:
28452423
7.

Enhanced Antibody Detection and Diagnosis of Coccidioidomycosis with the MiraVista IgG and IgM Detection Enzyme Immunoassay.

Malo J, Holbrook E, Zangeneh T, Strawter C, Oren E, Robey I, Erickson H, Chahal R, Durkin M, Thompson C, Hoover SE, Ampel NM, Wheat LJ, Knox KS.

J Clin Microbiol. 2017 Mar;55(3):893-901. doi: 10.1128/JCM.01880-16. Epub 2017 Jan 4.

8.

Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):717-22. doi: 10.1093/cid/ciw538.

PMID:
27559032
9.

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):e112-46. doi: 10.1093/cid/ciw360. Epub 2016 Jul 27.

PMID:
27470238
10.
11.

THE TREATMENT OF COCCIDIOIDOMYCOSIS.

Ampel NM.

Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:51-6. doi: 10.1590/S0036-46652015000700010. Review.

12.

Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.

Pasha AK, Walsh TK, Ampel NM.

Lung. 2015 Oct;193(5):863-4. doi: 10.1007/s00408-015-9764-0. Epub 2015 Jul 23. No abstract available.

PMID:
26202257
13.

Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.

Ampel NM, Nesbit LA, Nguyen CT, Chavez S, Knox KS, Johnson SM, Pappagianis D.

Clin Vaccine Immunol. 2015 Aug;22(8):917-22. doi: 10.1128/CVI.00280-15. Epub 2015 Jun 3.

14.

The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis.

Wack EE, Ampel NM, Sunenshine RH, Galgiani JN.

Clin Infect Dis. 2015 Sep 1;61(5):787-91. doi: 10.1093/cid/civ388. Epub 2015 May 15. Review.

PMID:
25979308
15.

Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.

Reyes N, Onadeko OO, Luraschi-Monjagatta Mdel C, Knox KS, Rennels MA, Walsh TK, Ampel NM.

Lung. 2014 Aug;192(4):589-93. doi: 10.1007/s00408-014-9589-2. Epub 2014 May 7.

PMID:
24801058
16.

Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN.

Clin Microbiol Rev. 2013 Jul;26(3):505-25. doi: 10.1128/CMR.00005-13. Review.

17.

Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis.

Nesbit LA, Knox KS, Nguyen CT, Roesch J, Wheat LJ, Johnson SM, Pappagianis D, Chavez S, Ampel NM.

J Infect Dis. 2013 Sep 1;208(5):857-63. doi: 10.1093/infdis/jit246. Epub 2013 Jun 3.

PMID:
23737603
18.

Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs.

Taroumian S, Knowles SL, Lisse JR, Yanes J, Ampel NM, Vaz A, Galgiani JN, Hoover SE.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1903-9. doi: 10.1002/acr.21784.

19.

A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.

Johnson R, Kernerman SM, Sawtelle BG, Rastogi SC, Nielsen HS, Ampel NM.

Mycopathologia. 2012 Dec;174(5-6):353-8. doi: 10.1007/s11046-012-9555-6. Epub 2012 Jun 6.

PMID:
22669545
20.

Coccidioidomycosis during pregnancy: a review and recommendations for management.

Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM.

Clin Infect Dis. 2011 Aug;53(4):363-8. doi: 10.1093/cid/cir410. Review.

PMID:
21810749
21.

What's Behind the Increasing Rates of Coccidioidomycosis in Arizona and California?

Ampel NM.

Curr Infect Dis Rep. 2010 May;12(3):211-6. doi: 10.1007/s11908-010-0094-3.

PMID:
21308532
22.

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, Davies SF, Dismukes WE, Hage CA, Marr KA, Mody CH, Perfect JR, Stevens DA; American Thoracic Society Fungal Working Group.

Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128. doi: 10.1164/rccm.2008-740ST.

PMID:
21193785
23.

The diagnosis of coccidioidomycosis.

Ampel NM.

F1000 Med Rep. 2010 Jan 18;2. pii: 2. doi: 10.3410/M2-2.

24.

New perspectives on coccidioidomycosis.

Ampel NM.

Proc Am Thorac Soc. 2010 May;7(3):181-5. doi: 10.1513/pats.200907-080AL. Review.

PMID:
20463246
25.

Measuring cellular immunity in coccidioidomycosis: the time is now.

Ampel NM, Hector RF.

Mycopathologia. 2010 Jun;169(6):425-6. doi: 10.1007/s11046-010-9285-6. Epub 2010 Feb 16. No abstract available.

PMID:
20157783
26.

Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy.

Masannat FY, Ampel NM.

Clin Infect Dis. 2010 Jan 1;50(1):1-7. doi: 10.1086/648719.

PMID:
19995218
27.

Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells.

Nesbit L, Johnson SM, Pappagianis D, Ampel NM.

Infect Immun. 2010 Jan;78(1):309-15. doi: 10.1128/IAI.00953-09. Epub 2009 Nov 9.

28.

Coccidioidomycosis: a review of recent advances.

Ampel NM.

Clin Chest Med. 2009 Jun;30(2):241-51, v. doi: 10.1016/j.ccm.2009.02.004. Review.

PMID:
19375631
29.

Mannose-binding lectin serum levels are low in persons with clinically active coccidioidomycosis.

Ampel NM, Dionne SO, Giblin A, Podany AB, Galgiani J.

Mycopathologia. 2009 Apr;167(4):173-80. doi: 10.1007/s11046-008-9172-6. Epub 2008 Dec 14.

PMID:
19083122
30.

Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis.

Ampel NM, Giblin A, Mourani JP, Galgiani JN.

Clin Infect Dis. 2009 Jan 15;48(2):172-8. doi: 10.1086/595687.

PMID:
19072555
31.

The complex immunology of human coccidioidomycosis.

Ampel NM.

Ann N Y Acad Sci. 2007 Sep;1111:245-58. Epub 2007 Mar 15. Review.

PMID:
17363432
32.

Coccidioidomycosis in persons infected with HIV-1.

Ampel NM.

Ann N Y Acad Sci. 2007 Sep;1111:336-42. Epub 2007 Mar 15. Review.

PMID:
17363429
33.
34.

Coccidioidomycosis as a common cause of community-acquired pneumonia.

Valdivia L, Nix D, Wright M, Lindberg E, Fagan T, Lieberman D, Stoffer T, Ampel NM, Galgiani JN.

Emerg Infect Dis. 2006 Jun;12(6):958-62. Erratum in: Emerg Infect Dis. 2006 Aug;12(8):1307.

35.

Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation.

Dionne SO, Podany AB, Ruiz YW, Ampel NM, Galgiani JN, Lake DF.

Infect Immun. 2006 Apr;74(4):2415-22.

37.

Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL; Infectious Diseases Society of America.

Clin Infect Dis. 2005 Nov 1;41(9):1217-23. Epub 2005 Sep 20. Review. No abstract available.

PMID:
16206093
38.

Coccidioidomycosis in persons infected with HIV type 1.

Ampel NM.

Clin Infect Dis. 2005 Oct 15;41(8):1174-8. Epub 2005 Sep 12. Review. Erratum in: Clin Infect Dis. 2005 Dec 15;41(12):1830.

PMID:
16163637
39.
40.

Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.

Ampel NM, Nelson DK, Chavez S, Naus KA, Herman AB, Li L, Simmons KA, Pappagianis D.

Clin Diagn Lab Immunol. 2005 Jun;12(6):700-4.

41.

The mannose receptor mediates the cellular immune response in human coccidioidomycosis.

Ampel NM, Nelson DK, Li L, Dionne SO, Lake DF, Simmons KA, Pappagianis D.

Infect Immun. 2005 Apr;73(4):2554-5.

42.

Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.

Bergstrom L, Yocum DE, Ampel NM, Villanueva I, Lisse J, Gluck O, Tesser J, Posever J, Miller M, Araujo J, Kageyama DM, Berry M, Karl L, Yung CM.

Arthritis Rheum. 2004 Jun;50(6):1959-66.

43.

Combating opportunistic infections: coccidioidomycosis.

Ampel NM.

Expert Opin Pharmacother. 2004 Feb;5(2):255-61. Review.

PMID:
14996623
44.

Measurement of cellular immunity in human coccidioidomycosis.

Ampel NM.

Mycopathologia. 2003;156(4):247-62. Review.

PMID:
14682448
45.

The solitary pulmonary nodule.

Ampel NM.

N Engl J Med. 2003 Oct 16;349(16):1575; author reply 1575. No abstract available.

PMID:
14561804
46.

In vitro modulation of cytokine production by lymphocytes in human coccidioidomycosis.

Ampel NM, Kramer LA.

Cell Immunol. 2003 Feb;221(2):115-21.

PMID:
12747952
47.

In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.

Ampel NM, Kramer LA, Li L, Carroll DS, Kerekes KM, Johnson SM, Pappagianis D.

Clin Diagn Lab Immunol. 2002 Sep;9(5):1039-43.

48.
50.

Introduction. Symposium on coccidioidomycosis.

Ampel NM.

Semin Respir Infect. 2001 Dec;16(4):229-30. Review. No abstract available.

PMID:
11740822

Supplemental Content

Loading ...
Support Center